The California Supreme Court sided with Gilead Sciences in a closely watched case over whether the company had a "duty" to ...

Two people have died in the cyclospora outbreak in Michigan in the first confirmed deaths in the U.S. related to the ...

It is no longer possible to ask the FDA to keep pace with software development by doing the same reviews faster,” writes Dana ...

Medicare is removing flexibilities that have allowed 'breakthrough' medical devices to leapfrog qualifications for extra ...

Medicaid work requirements in effect in Nebraska, AI scribes in med school, and more health news from Morning Rounds ...

Losing the ability to speak has taught me how quickly society conflates physical dependence with diminished personhood,” writes Dr. Christopher Campos.

Six weeks after STAT reported that Eli Lilly granted a single 79-year-old patient special access to retatrutide, an ...

A White House proposal to subject research grants to political scrutiny meets at least a temporary roadblock in the Senate.

AstraZeneca stock fell as investors balked at reports of merger talks with Bristol Myers Squibb about forming one of ​the world's biggest drugmakers ...

Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical ...

The leaders of the Federation of State Medical Boards weigh in on the question of licensing AI to practice medicine.

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...